Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NNOX 
Nano X Imaging Ltd (NNOX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/21/2025: NNOX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $7.75
1 Year Target Price $7.75
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.76% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/21/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 269.83M USD | Price to earnings Ratio - | 1Y Target Price 7.75 |
Price to earnings Ratio - | 1Y Target Price 7.75 | ||
Volume (30-day avg) 4 | Beta 1.88 | 52 Weeks Range 3.60 - 11.00 | Updated Date 10/21/2025 |
52 Weeks Range 3.60 - 11.00 | Updated Date 10/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.95 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -475.59% |
Management Effectiveness
Return on Assets (TTM) -18.97% | Return on Equity (TTM) -32.87% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 198336159 | Price to Sales(TTM) 22.7 |
Enterprise Value 198336159 | Price to Sales(TTM) 22.7 | ||
Enterprise Value to Revenue 16.69 | Enterprise Value to EBITDA -7.41 | Shares Outstanding 63939620 | Shares Floating 61156328 |
Shares Outstanding 63939620 | Shares Floating 61156328 | ||
Percent Insiders 0.23 | Percent Institutions 20.9 |
Upturn AI SWOT
Nano X Imaging Ltd
Company Overview
History and Background
Nano X Imaging Ltd. (Nanox) was founded in 2018. It aims to revolutionize medical imaging by developing a more accessible and affordable digital X-ray source based on microelectromechanical systems (MEMS) technology. The company has focused on developing its Nanox.ARC imaging system and related services.
Core Business Areas
- Medical Imaging Systems: Development and commercialization of the Nanox.ARC digital X-ray system, intended to provide 3D tomosynthesis imaging at a lower cost and smaller footprint compared to traditional CT scanners.
- Cloud-Based Services: Deployment of Nanox.CLOUD, a cloud-based infrastructure designed to support the Nanox.ARC system, offering image storage, analysis, and connectivity services.
- Pay-Per-Scan Business Model: The company plans to operate a pay-per-scan business model, partnering with medical providers to offer imaging services to patients on a subscription or usage basis.
Leadership and Structure
The CEO is Erez Meltzer. The organizational structure includes departments for research and development, manufacturing, sales and marketing, and cloud services. Board of Directors includes prominent figures in healthcare and technology.
Top Products and Market Share
Key Offerings
- Nanox.ARC: A digital X-ray source utilizing MEMS technology intended to replace traditional X-ray tubes. It is designed for whole-body imaging. While still pre-commercialization, projected cost is lower. Competitors include GE Healthcare, Siemens Healthineers, and Philips Healthcare. Current market share is negligible due to it being pre-commercialization.
- Nanox.CLOUD: A cloud-based platform for storing, analyzing, and sharing medical images acquired using the Nanox.ARC system. It also supports the company's pay-per-scan business model. Market share is also negligible due to the product being pre-commercialization. Competitors include Sectra, Philips Intellispace, and IBM Watson Health (now Merative).
Market Dynamics
Industry Overview
The medical imaging industry is a large and growing market, driven by increasing demand for diagnostic imaging services. Trends include increasing adoption of digital imaging technologies, rising prevalence of chronic diseases, and growing geriatric population.
Positioning
Nanox aims to disrupt the traditional medical imaging market by offering a more accessible and affordable digital X-ray solution. The company's competitive advantage lies in its MEMS-based technology, which potentially offers lower manufacturing costs and a smaller device footprint.
Total Addressable Market (TAM)
The global medical imaging market is estimated to be over $40 billion. Nanox is positioned to capture a portion of this TAM by providing a cheaper imaging system to underserved locations worldwide.
Upturn SWOT Analysis
Strengths
- Innovative MEMS-based X-ray technology
- Potential for lower manufacturing costs
- Compact and portable design
- Pay-per-scan business model
- Cloud-based service platform
Weaknesses
- Pre-commercialization stage
- Unproven technology
- Regulatory hurdles for approval
- Limited operating history
- Reliance on third-party manufacturers
Opportunities
- Expansion into underserved markets
- Partnerships with healthcare providers
- Integration with AI-based diagnostic tools
- Development of new imaging applications
- Growth in telemedicine and remote monitoring
Threats
- Competition from established medical imaging companies
- Technological obsolescence
- Changes in healthcare regulations
- Economic downturn
- Product recalls
Competitors and Market Share
Key Competitors
- GE HealthCare Technologies Inc. (GEHC)
- Siemens Healthineers AG (SEMHF)
- Koninklijke Philips N.V. (PHG)
Competitive Landscape
Nanox's competitive advantage lies in its innovative MEMS-based technology, which has the potential to significantly reduce costs. However, Nanox faces significant challenges from established medical imaging giants with extensive resources, brand recognition, and existing customer relationships.
Major Acquisitions
Zebra Medical Vision
- Year: 2021
- Acquisition Price (USD millions): 200
- Strategic Rationale: Acquired to enhance Nanox's AI capabilities for medical image analysis and diagnosis.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited due to the company's pre-commercialization stage. Growth has primarily focused on product development and securing regulatory approvals.
Future Projections: Future growth projections are dependent on the successful commercialization of the Nanox.ARC system and the adoption of the pay-per-scan business model. Analyst estimates vary widely, reflecting uncertainty about the company's prospects.
Recent Initiatives: Recent strategic initiatives include securing FDA clearance for the Nanox.ARC system, expanding manufacturing capacity, and establishing partnerships with healthcare providers.
Summary
Nano X Imaging Ltd. is a speculative investment with significant potential, contingent on the successful commercialization of its Nanox.ARC technology. The company's innovative approach to digital X-ray imaging and its pay-per-scan business model could disrupt the traditional medical imaging market. However, it faces substantial challenges, including regulatory hurdles, competition from established players, and the need to demonstrate the long-term viability of its technology. Its current lack of substantial revenue and ongoing losses demand careful monitoring by investors. Regulatory setbacks and market acceptance are key risks to consider.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. The information provided is based on publicly available data and analyst estimates, which are subject to change. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nano X Imaging Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-08-21 | CEO & Acting Chairman of the Board Mr. Erez I. Meltzer | ||
Sector Healthcare | Industry Medical Devices | Full time employees 165 | Website https://www.nanox.vision |
Full time employees 165 | Website https://www.nanox.vision | ||
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.